Health
5.2
AstraZeneca to Present Survival Data from Four Phase 3 Trials at ESMO 2026
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateDagens IndustriLow-rated source
Caliway Biopharmaceuticals has developed an injectable therapy that acts via a novel mechanism, potentially offering relief to millions. The claim is based on promotional material and lacks clinical data or regulatory milestones. If approved, it could represent a significant therapeutic advance, but efficacy and safety remain unverified.
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 19 h ago1 sourceEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 21 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported